{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:20:05Z","timestamp":1778692805863,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017366","name":"Key Research and Development Program of Heilongjiang","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.intimp.2026.116434","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T06:25:17Z","timestamp":1772432717000},"page":"116434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["MicroRNA-375 promotes tamoxifen resistance by stabilizing ER\u03b1 via UBE3A-mediated ubiquitination"],"prefix":"10.1016","volume":"175","author":[{"given":"Dinglong","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazhuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaru","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longxu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guannan","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingwei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.116434_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.intimp.2026.116434_bb0010","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41568-023-00604-3","article-title":"Therapeutic resistance to anti-oestrogen therapy in breast cancer","volume":"23","author":"Will","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"7381","key":"10.1016\/j.intimp.2026.116434_bb0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature10730","article-title":"Differential oestrogen receptor binding is associated with clinical outcome in breast cancer","volume":"481","author":"Ross-Innes","year":"2012","journal-title":"Nature"},{"issue":"9472","key":"10.1016\/j.intimp.2026.116434_bb0020","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2026.116434_bb0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2026.116434_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.intimp.2026.116434_bb0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12964-023-01268-0","article-title":"Exo-miR-1290-induced by COX-2 overexpression promotes cancer-associated fibroblasts activation and tumor progression by CUL3-Nrf2 pathway in lung adenocarcinoma","volume":"21","author":"Bai","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.intimp.2026.116434_bb0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12943-018-0818-9","article-title":"miR-190 suppresses breast cancer metastasis by regulation of TGF-\u03b2-induced epithelial-mesenchymal transition","volume":"17","author":"Yu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2026.116434_bb0045","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s12276-022-00837-6","article-title":"MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4\/STAT3 axis","volume":"54","author":"Gan","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116434_bb0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41420-023-01499-7","article-title":"MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation","volume":"9","author":"Gan","year":"2023","journal-title":"Cell Death Discov."},{"issue":"4","key":"10.1016\/j.intimp.2026.116434_bb0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neo.2014.03.010","article-title":"SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells","volume":"16","author":"Hong","year":"2014","journal-title":"Neoplasia"},{"issue":"22","key":"10.1016\/j.intimp.2026.116434_bb0060","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1158\/0008-5472.CAN-10-1318","article-title":"Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells","volume":"70","author":"de Souza Rocha Simonini","year":"2010","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.intimp.2026.116434_bb0065","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/onc.2012.128","article-title":"Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer","volume":"32","author":"Ward","year":"2013","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.intimp.2026.116434_bb0070","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s00018-015-1887-1","article-title":"The novel role of miRNAs for tamoxifen resistance in human breast cancer","volume":"72","author":"Zhang","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.116434_bb0075","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.7150\/ijbs.69411","article-title":"The role of ubiquitination and deubiquitination in tumor invasion and metastasis","volume":"18","author":"Han","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.116434_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020539","article-title":"E3 ubiquitin ligase NEDD4 affects estrogen receptor \u03b1 expression and the prognosis of patients with hormone receptor-positive breast Cancer","volume":"15","author":"Natori","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.intimp.2026.116434_bb0085","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2183\/pjab.93.030","article-title":"Intrinsic ubiquitin E3 ligase activity of histone acetyltransferase Hbo1 for estrogen receptor \u03b1","volume":"93","author":"Iizuka","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.116434_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.47","article-title":"Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-\u03b1 protein turnover","volume":"6","author":"Zhang","year":"2015","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.intimp.2026.116434_bb0095","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/onc.2013.78","article-title":"Pin1 modulates ER\u03b1 levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation","volume":"33","author":"Rajbhandari","year":"2014","journal-title":"Oncogene"},{"issue":"44","key":"10.1016\/j.intimp.2026.116434_bb0100","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1038\/s41388-020-01464-z","article-title":"The ubiquitin ligase RNF181 stabilizes ER\u03b1 and modulates breast cancer progression","volume":"39","author":"Zhu","year":"2020","journal-title":"Oncogene"},{"issue":"25","key":"10.1016\/j.intimp.2026.116434_bb0105","article-title":"The E3 ligase TRIM4 facilitates SET ubiquitin-mediated degradation to enhance ER-\u03b1 action in breast Cancer","volume":"9","author":"Han","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"34","key":"10.1016\/j.intimp.2026.116434_bb0110","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1038\/onc.2013.573","article-title":"The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor \u03b1 and modulates estrogen-stimulated breast cancer cell proliferation","volume":"33","author":"Zhu","year":"2014","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.intimp.2026.116434_bb0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cac2.12417","article-title":"Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer","volume":"43","author":"Guo","year":"2023","journal-title":"Cancer Commun. (Lond.)"},{"issue":"4","key":"10.1016\/j.intimp.2026.116434_bb0125","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.1038\/cddis.2013.120","article-title":"E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C\/EBP\u03b1 for ubiquitin-mediated proteasome degradation","volume":"4","author":"Pal","year":"2013","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.intimp.2026.116434_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065330","article-title":"E3 ubiquitin ligase E6AP negatively regulates adipogenesis by downregulating proadipogenic factor C\/EBPalpha","volume":"8","author":"Pal","year":"2013","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.intimp.2026.116434_bb0135","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.bbrc.2020.05.188","article-title":"HIV-1 Nef promotes ubiquitination and proteasomal degradation of p53 tumor suppressor protein by using E6AP","volume":"529","author":"Ali","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"44","key":"10.1016\/j.intimp.2026.116434_bb0140","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114258118","article-title":"Calcineurin regulates the stability and activity of estrogen receptor \u03b1","volume":"118","author":"Masaki","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.intimp.2026.116434_bb0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrc3093","article-title":"The different roles of ER subtypes in cancer biology and therapy","volume":"11","author":"Thomas","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.116434_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.845048","article-title":"Targeting MALT1 suppresses the malignant progression of colorectal Cancer via miR-375\/miR-365a-3p\/NF-\u03baB Axis","volume":"10","author":"Qian","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116434_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41419-017-0134-0","article-title":"miR-375 is involved in hippo pathway by targeting YAP1\/TEAD4-CTGF axis in gastric carcinogenesis","volume":"9","author":"Kang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.116434_bb0160","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.omtn.2018.04.007","article-title":"The ASH1-miR-375-YWHAZ signaling Axis regulates tumor properties in hepatocellular carcinoma","volume":"11","author":"Zhao","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.intimp.2026.116434_bb0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13046-020-01631-w","article-title":"Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression","volume":"39","author":"He","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.intimp.2026.116434_bb0170","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1007\/s12010-023-04375-3","article-title":"Deregulation of miR-375 inhibits HOXA5 and promotes migration, invasion, and cell proliferation in breast Cancer","volume":"195","author":"Moorthy","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"22","key":"10.1016\/j.intimp.2026.116434_bb0175","doi-asserted-by":"crossref","first-page":"E4482","DOI":"10.1073\/pnas.1620993114","article-title":"Embryonic transcription factor SOX9 drives breast cancer endocrine resistance","volume":"114","author":"Jeselsohn","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.intimp.2026.116434_bb0180","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrclinonc.2015.117","article-title":"ESR1 mutations\u2014a mechanism for acquired endocrine resistance in breast cancer","volume":"12","author":"Jeselsohn","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116434_bb0185","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","article-title":"The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53","volume":"75","author":"Scheffner","year":"1993","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.intimp.2026.116434_bb0190","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/pmic.201100572","article-title":"Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells","volume":"12","author":"Lochab","year":"2012","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.intimp.2026.116434_bb0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41419-023-05552-2","article-title":"FRMD3 inhibits the growth and metastasis of breast cancer through the ubiquitination-mediated degradation of vimentin and subsequent impairment of focal adhesion","volume":"14","author":"Shao","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116434_bb0200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10549-011-1567-2","article-title":"Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis","volume":"132","author":"Ramamoorthy","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.intimp.2026.116434_bb0205","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/MCB.19.2.1182","article-title":"The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily","volume":"19","author":"Nawaz","year":"1999","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116434_bb0210","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.mce.2011.04.021","article-title":"Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy","volume":"348","author":"Johnson","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116434_bb0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2009.06.017","article-title":"Oestrogen receptor splice variants in the pathogenesis of disease","volume":"288","author":"Taylor","year":"2010","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.intimp.2026.116434_bb0220","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tem.2012.03.002","article-title":"miRNAs and estrogen action","volume":"23","author":"Klinge","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2026.116434_bb0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cca.2016.06.004","article-title":"Steroid receptor RNA activator: biologic function and role in disease","volume":"459","author":"Liu","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.intimp.2026.116434_bb0230","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1210\/er.2010-0016","article-title":"Cracking the estrogen receptor\u2019s posttranslational code in breast tumors","volume":"32","author":"Le Romancer","year":"2011","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2026.116434_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040500","article-title":"Estrogen receptors and ubiquitin proteasome system: mutual regulation","volume":"10","author":"Kondakova","year":"2020","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.intimp.2026.116434_bb0240","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1210\/en.2004-1198","article-title":"Decreased expression of e6-associated protein in breast and prostate carcinomas","volume":"146","author":"Gao","year":"2005","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.intimp.2026.116434_bb0245","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/me.2005-0110","article-title":"Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland","volume":"20","author":"Khan","year":"2006","journal-title":"Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116434_bb0250","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1097-2765(03)00090-X","article-title":"Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling","volume":"11","author":"Reid","year":"2003","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.intimp.2026.116434_bb0255","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41419-024-06979-x","article-title":"UBE2M forms a positive feedback loop with estrogen receptor to drive breast cancer progression and drug resistance","volume":"15","author":"Lin","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.intimp.2026.116434_bb0260","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/1078-0432.CCR-13-2332","article-title":"Emergence of constitutively active estrogen receptor-\u03b1 mutations in pretreated advanced estrogen receptor-positive breast cancer","volume":"20","author":"Jeselsohn","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"15","key":"10.1016\/j.intimp.2026.116434_bb0265","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.7150\/jca.59740","article-title":"HOXA5 confers tamoxifen resistance via the PI3K\/AKT signaling pathway in ER-positive breast cancer","volume":"12","author":"Kim","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.intimp.2026.116434_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106092","article-title":"Tumor suppressor functions of miRNA-375 in nasopharyngeal carcinoma through inhibition of ubiquitin-specific protease 1 expression","volume":"141","author":"Xu","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116434_bb0275","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.1996.14.9.2584","article-title":"Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy","volume":"14","author":"Kuukasj\u00e4rvi","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116434_bb0280","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/1541-7786.MCR-23-0321","article-title":"Progress in the understanding of estrogen receptor alpha signaling in triple-negative breast Cancer: reactivation of silenced ER-\u03b1 and signaling through ER-\u03b136","volume":"21","author":"Al-Kabariti","year":"2023","journal-title":"Mol. Cancer Res."},{"issue":"17","key":"10.1016\/j.intimp.2026.116434_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179521","article-title":"Advances of epigenetic biomarkers and epigenome editing for early diagnosis in breast Cancer","volume":"23","author":"Sarvari","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.intimp.2026.116434_bb0290","first-page":"7025","article-title":"Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells","volume":"61","author":"Yang","year":"2001","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.intimp.2026.116434_bb0295","first-page":"6890","article-title":"Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition","volume":"60","author":"Yang","year":"2000","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116434_bb0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4161\/cbt.6.1.3549","article-title":"Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation","volume":"6","author":"Zhou","year":"2007","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2026.116434_bb0305","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.16","article-title":"The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ER\u03b1 expression and enhances hormonal therapy for breast cancer","volume":"4","author":"Hait","year":"2015","journal-title":"Oncogenesis"},{"key":"10.1016\/j.intimp.2026.116434_bb0310","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-12-9","article-title":"Epigenetic reactivation of estrogen receptor-\u03b1 (ER\u03b1) by genistein enhances hormonal therapy sensitivity in ER\u03b1-negative breast cancer","volume":"12","author":"Li","year":"2013","journal-title":"Mol. Cancer"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600278X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600278X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:15:19Z","timestamp":1777619719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692600278X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":61,"alternative-id":["S156757692600278X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116434","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-375 promotes tamoxifen resistance by stabilizing ER\u03b1 via UBE3A-mediated ubiquitination","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116434"}}